List of insiders holdings for GW PHARMACEUTICALS PLC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | Gangolli Julian S President, North America |
2019-05-14 21:00:24 | 117,151 0 |
117,151 | Form 4 |
2 | Lynch Thomas G Director |
2019-03-05 21:04:08 | 25,980 0 |
25,980 | Form 4 |
3 | George Adam D. Secretary |
2021-01-25 19:37:07 | 24,700 0 |
24,700 | Form 4 |
4 | Waldegrave William A. Director |
2021-05-07 16:15:16 | 0 0 |
0 | Form 4 |
5 | Brown Cabot Director |
2021-05-07 16:15:23 | 0 0 |
0 | Form 4 |
6 | Gover Justin D. Chief Executive Officer |
2021-05-07 16:15:42 | 0 0 |
0 | Form 4 |
7 | GUY GEOFFREY W DR Executive Chairman |
2021-05-07 16:15:35 | 0 0 |
0 | Form 4 |
8 | Giacobello Scott M. Chief Financial Officer |
2021-05-07 16:15:31 | 0 0 |
0 | Form 4 |
9 | MACKEY CATHERINE J Director |
2021-05-07 16:15:37 | 0 0 |
0 | Form 4 |
10 | Knappertz Volker Chief Medical Officer |
2021-05-07 16:15:36 | 0 0 |
0 | Form 4 |
11 | Secor Alicia Director |
2021-05-07 16:15:31 | 0 0 |
0 | Form 4 |
12 | Noble James Director |
2021-05-07 16:15:39 | 0 0 |
0 | Form 4 |
13 | Snyder Douglas B. Chief Legal Officer |
2021-05-07 16:15:52 | 0 0 |
0 | Form 4 |
14 | GRYSKA DAVID W Director |
2021-05-07 16:19:12 | 0 0 |
0 | Form 4 |
15 | Cline Darren S U.S. Chief Commercial Officer |
2021-05-07 16:21:57 | 0 0 |
0 | Form 4 |
16 | Tovey Christopher J. Chief Operating Officer |
2021-05-07 16:25:12 | 0 0 |
0 | Form 4 |